July 22, 2013
A Delaware federal judge on Monday ruled that Mylan Pharmaceuticals Inc. infringed three patents for Cephalon Inc.'s cancer painkiller drug Fentora, saying the former company's proposed generic version of the drug includes components covered by the patents.
February 28, 2011
Cephalon Inc. and Cima Labs Inc. launched a patent infringement suit against Mylan Inc. in Delaware on Friday, targeting the company over its attempts to market a generic version of Cephalon's cancer painkiller drug Fentora.